NCX 905Alternative Names: Timolol-NO
Latest Information Update: 16 Aug 2002
At a glance
- Originator NicOx
- Class Antiglaucomas
- Mechanism of Action Beta-adrenergic receptor antagonists; Nitric oxide donors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Glaucoma
Most Recent Events
- 02 May 2000 New profile
- 02 May 2000 Preclinical development for Glaucoma in France (Unknown route)